IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-28 |
2024-03 |
-0.08 |
-0.08 |
N/A |
N/A |
2024-04-03 |
2023-12 |
0 |
N/A |
N/A |
N/A |
2024-04-03 |
2023-12 |
0 |
-0.07 |
N/A |
N/A |
2023-11-15 |
2023-09 |
-0.09 |
-0.09 |
N/A |
N/A |
2023-11-15 |
2023-09 |
-0.09 |
N/A |
N/A |
N/A |
2023-08-14 |
2023-06 |
-0.09 |
N/A |
N/A |
N/A |
Split |
Date |
1 : 8 |
2021-08-09 |